About TomoTherapy
TomoTherapy is a company based in Madison (United States) founded in 1997 by Thomas Rock was acquired by Accuray in March 2011. TomoTherapy has raised $17.74 million across 3 funding rounds from investors including Accuray, The Endeavor Group and Ascension Ventures. TomoTherapy offers products and services including Radixact System, CyberKnife, and TomoTherapy. TomoTherapy operates in a competitive market with competitors including RefleXion, Alpha Tau Medical, Mevion Medical Systems, ZAP-X and ABK Biomedical, among others.
- Headquarter Madison, United States
- Founders Thomas Rock
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Tomotherapy, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of TomoTherapy
TomoTherapy offers a comprehensive portfolio of products and services, including Radixact System, CyberKnife, and TomoTherapy.
Delivers precise radiation for cancer treatment using imaging guidance.
Provides non-invasive robotic treatment for tumors.
Offers integrated system for comprehensive cancer care delivery.
People of TomoTherapy
Unlock access to complete
Unlock access to complete
Funding Insights of TomoTherapy
TomoTherapy has successfully raised a total of $17.74M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $7 million completed in February 2004. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in TomoTherapy
TomoTherapy has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Accuray, The Endeavor Group and Ascension Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Strategic investments in healthcare technologies and data innovations.
|
Locked | Locked | Locked | |
|
Private equity investment firm
|
Locked | Locked | Locked | |
|
Private equity fund management is provided by Open Prairie.
|
Locked | Locked | Locked |
Investor details for TomoTherapy
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TomoTherapy
Investment portfolio details for TomoTherapy
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - TomoTherapy
Detailed financials for TomoTherapy
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tomotherapy Comparisons
Peer comparison for TomoTherapy
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TomoTherapy
TomoTherapy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as RefleXion, Alpha Tau Medical, Mevion Medical Systems, ZAP-X and ABK Biomedical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biology-guided radiotherapy systems are provided for cancer treatment.
|
|
| Locked | Locked | Locked |
Radiotherapy technique for solid tumors is developed using alpha-emitting seeds.
|
|
| Locked | Locked | Locked |
Proton therapy systems are supplied for cancer radiation treatment.
|
|
| Locked | Locked | Locked |
Developer of gyroscopic radiosurgery platform
|
|
| Locked | Locked | Locked |
Imageable embolic devices are developed for hypervascular tumors.
|
|
| Locked | Locked | Locked |
Targeted radiopharmaceuticals are developed for solid tumor treatment.
|
Detailed competitors of TomoTherapy
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tomotherapy
Complete news archive for TomoTherapy
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TomoTherapy
TomoTherapy was founded in 1997 and raised its 1st funding round 5 years after it was founded.
TomoTherapy is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.
TomoTherapy is a funded company, having raised a total of $17.74M across 3 funding rounds to date.
TomoTherapy was founded in 1997 in Madison, United States, as a developer of radiation therapy systems within the medical devices sector. Operations focus on integrating CT imaging with conformal radiation therapy to treat cancers while minimizing exposure to healthy tissues. The Hi-Art system is provided as a key solution for diverse cancer types. Co-founder Thomas Rock contributed to its establishment, with activities centered in oncology applications.
TomoTherapy's top competitors include RefleXion, Alpha Tau Medical and Starget Pharma.
TomoTherapy offers Radixact System, CyberKnife, and TomoTherapy.
TomoTherapy has 6 investors. Key investors include Accuray, The Endeavor Group, Ascension Ventures, Advantage Capital, and Open Prairie.